An integrated drug repositioning analysis identifies rosiglitazone as a treatment for sarcopenia.

Commun Biol · 2026 · PMC13022187 · PMID 41611847

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Gut microbiota alterations induced by rosiglitazone The intestinal microbiota of the rosiglitazone group exhibited a trend towards increased alpha diversity, although this trend did not reach statistical significance (Fig. 7A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.